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Dialysis S119Results: The average BDI score and PSQI score of the CAPD patients were
12.1 7.9 and 6.6 4.0, with 23(40.4%) depressed patients (BDI
score > OR Z 16) and 37 (64.9%) poor sleepers (PSQI scores > OR Z 5). In
univariate analysis, the BDI score was positively correlated with serum b2
microglobulin (r Z 0.255, P Z 0.011) and Peritoneal Kt/Vurea (r Z 6.289,
PZ 0.038), While the PSQI score was negatively correlated with serum albu-
min (r Z 0.333, P Z 0.007) and positively correlated with high-sensitivity
C-reactive protein (r Z 0.014, P Z 0.016), duration on CAPD (r Z 0.084,
P Z 0.009), serum creatinine (r Z 0.005, P Z 0.013), serum phosphate
(r Z 2.186, P Z 0.034), serum b2 microglobulin (r Z 0.184, P < 0.01) and
Peritoneal Kt/Vurea (rZ 3.409, PZ 0.018). In multiple analysis, high serum
b2 microglobulin (b Z 0.301, P Z 0.010) was the independent predictor of
depression in CAPD patients, and long duration on CAPD (b Z 0.129,
P Z 0.003) was the only risk factor for sleep disturbance in CAPD patients.
Conclusion: Depression and sleep disturbance are common in Chinese CAPD
patients. Close relationships exist between serum b2 microglobulin and
depression, duration on CAPD and poor sleep quality.http://dx.doi.org/10.1016/j.hkjn.2015.09.1770080
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Objective: Cast nephropathy in multiple myeloma is a consequence of high
serum levels of immunoglobulin free light chains (FLC). Excess monoclonal
FLC results in obstructing intratubular cast formation and tubular toxicity
causing acute kidney injury (AKI). This study aims to investigate the efficacy
of serum FLC removal by high cut-off haemodialysis (HCO-HD) in patients
with cast nephropathy.
Methods: From 9/2012-9/2013, 3 patients (patients 1, 2 and 3) with dialysis-
dependent AKI secondary to biopsy-proven cast nephropathy were started on
HCO-HD. All were Chinese; 2 females, 1 male, withmean age 65.3 years. Ultra-
flux EMiC2 dialyzer (polysulfone, surface area 1.8m2, cut-off 40kDa, albumin
sieving coefficient 0.01, Fresenius Medical Care, Germany) was used. Pre-
&post-HCO-HD serum FLC and albumin levels were retrospectively reviewed.
Results: Patient 1 had IgA-lambda myeloma with high serum lambda FLC level
and patients 2 and 3 had kappa light chain myeloma with high serum kappa
FLC level. Their mean serum creatinine level on presentation was 755
mmol/L and serum FLC levels of patients 1, 2 and 3 were 14,800, 12,231
and 11,200 mg/L respectively. All patients were treated with 6 daily sessions
of extended HCO-HD, 8 hours/session with blood flow rate 150e200 ml/min.
Bortezomib-based chemotherapy was started on the day of 2nd HD session in
patient 1 and 5th HD session in patient 2, and 1 day before HCO-HD in patient
3. The mean % reduction of serum FLC level after each HD session in patients
1, 2 and 3 were 17.8%, 73.7% and 57.9%, and the % reduction after 6 sessions of
HCO-HD were 55.7%, 88.3% and 85.4% respectively. Albumin infusion of
20e220 g during the 6 HCO-HD sessions was required and there was no
decrease in serum albumin post-HCO-HD. 1/3 patients (patient 1) became
dialysis independent after HCO-HD.
Conclusion: High cut-off hemodialysis using Ultraflux EMiC2 dialyzer com-
bined with bortezomib-based chemotherapy effectively removes serum
FLC in patients with cast nephropathy. Further prospective studies are
needed to assess whether HCO-HD can improve renal or patient survival.http://dx.doi.org/10.1016/j.hkjn.2015.09.1780103
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High glucose (HG) induced epithelial-mesenchymal transition (EMT) of
primary human peritoneal mesothelial cells (HPMCs) is characterized by
markers, as E-cadherin and claudins. Our previous study showed that serum
response factor (SRF), a transcription factor that binds to CArG boxes, is a
major regulator of HPMCs EMT and fibrosis. However, the target and pathway
of SRF in PD process has not to be elucidated. All these immortal HPMCs were
characterized by phenotype markers and tested the expression of SRF and
miRNA-199a/214 cluster by real time PCR andWestern blot. Our study showed
that a series of miRNAs, such as miR-214/miR-199a-5p cluster from selected
primary HPMCs miRNA array and have CArG element in the promotor, were
found to be regulated by SRF. ChIP and luciferase reporter assays revealed
that nuclear translocation of SRF directly promotes the transcription of miR-
214 and miR-199a-5p, which are examined to be highly expressed in HG-
induced HPMCs. Depletion ofmiR-214/miR-199a cluster in HPMCs reduces EMT
marking by up-regulating E-cadherin, claudins and downregulating a-SMA in
vitro. Mechanistically, miR-199a-5p andmiR-214 were characterized to target
the E-cadherin and claudin-2 messenger RNA CDH1 and CLDN2 to contribute to
the epithelial-mesenchymal transition (EMT). Together, this study reveals a
novel function of SRF in HPMCs EMTand fibrosis and identified a new SRF-miR-
199a/miR-214 cluster-CDH1/CLDN2 EMT axis which highlights the potential
association between TFs and miRNA-mediated EMT and fibrosis in PD.http://dx.doi.org/10.1016/j.hkjn.2015.09.179
